AVECRIS
AVECRIS Pte. Ltd. is a biotechnology company based in Singapore.1) It is developing a non-viral gene delivery platform for use in gene therapy and genetic vaccination.2)
Organization
Investors
Alameda Research invested in AVECRIS.3)
AVECRIS also participated in the 2022 cohort of First Flight Venture Center (FFVC)'s WheelsUP Accelerator, co-funded by the Biomedical Advanced Research and Development Authority (BARDA).4)
In July 2022, AVECRIS was selected as a winner of the Golden Ticket Competition by the Bakar BioEnginuity Hub and the Cystic Fibrosis Foundation.5)
Personnel
| Name | Position | Notes |
|---|---|---|
| Dennis Mak | CEO | - |
| Sushmita Poddar | Director of R&D | - |
| Rachel Loh | Research Scientist | - |
| Volker Patzel | Chief Scientific Officer | - |
1)
AVECRIS PTE. LTD. (201735118Z). Companies.sg. Retrieved March 26, 2023, from https://www.companies.sg/business/201735118Z/AVECRIS-PTE-LTD-
2)
Home. AVECRIS. Retrieved December 7, 2021, from https://web.archive.org/web/20211207084703/http://avecris.com/
3)
Shubber, K., & Elder, B. (2022, December 6). Revealed: the Alameda venture capital portfolio. Financial Times. http://archive.today/2023.03.26-162037/https://www.companies.sg/business/201735118Z/AVECRIS-PTE-LTD-
4)
WheelsUP Accelerator. First Flight Venture Center. Retrieved March 26, 2023, from http://archive.today/2023.03.26-162652/https://www.ffvcnc.org/wheelsup
5)
CF Foundation and Bakar Labs Announce Winners of First-Ever Golden Ticket Competition. (2022, July 21). Cystic Fibrosis Foundation. http://archive.today/2023.03.26-163323/https://www.cff.org/news/2022-07/first-ever-golden-ticket-winners